PANTHERx® Rare, a leading provider of patient access and support services for rare disease therapies in the United States, has launched RxARECONCIERGE™, an innovative...
IRBM, an integrated Contract Research Organization (CRO) specializing in preclinical drug discovery, has established a comprehensive Functional Genomics Platform to support genetic target identification...
AustinPx, a contract development and manufacturing organization specializing in bioavailability enhancement for orally delivered small molecule drugs, announced the introduction of the KinetiLease™ program,...
Orna Therapeutics, a biotechnology company dedicated to engineering immune cells in vivo to treat oncology and autoimmune diseases, announced the appointment of Joseph Bolen, Ph.D., as...
Alector, a late-stage clinical biotechnology company focused on developing therapies to counteract the devastating progression of neurodegeneration, announced that Gary Romano, M.D., Ph.D., has...
